CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer

Romie Angelo G. Azur,Kevin Christian V. Olarte,Weand S. Ybañez,Alessandria Maeve M. Ocampo,Pia D. Bagamasbad

DOI: https://doi.org/10.1101/2024.02.29.582710

2024-03-03

Abstract:Castration-resistant prostate cancer (CRPC) is associated with resistance to androgen deprivation therapy, and an increase in the population of neuroendocrine (NE) differentiated cells. It is hypothesized that NE differentiated cells secrete neuropeptides that support androgen-independent tumor growth and induce aggressiveness of adjacent proliferating tumor cells through a paracrine mechanism. The cytochrome b561 ( ) gene, which codes for a secretory vesicle transmembrane protein, is constitutively expressed in NE cells and highly expressed in CRPC. CYB561 is involved in the α-amidation-dependent activation of neuropeptides, and contributes to regulating iron metabolism which is often dysregulated in cancer. These findings led us to hypothesize that CYB561 may be a key player in the NE differentiation process that drives the progression and maintenance of the highly aggressive NE phenotype in CRPC. In our study, we found that expression is upregulated in metastatic and NE prostate cancer (NEPC) tumors and cell lines compared to normal prostate epithelia, and that its expression is independent of androgen regulation. Knockdown of in androgen-deprived LNCaP cells dampened NE differentiation potential and transdifferentiation-induced increase in iron levels. In NEPC PC-3 cells, depletion of CYB561 reduced the secretion of growth-promoting factors, lowered intracellular ferrous iron concentration, and mitigated the highly aggressive nature of these cells in complementary assays for cancer hallmarks. These findings demonstrate the role of CYB561 in facilitating transdifferentiation and maintenance of NE phenotype in CRPC through its involvement in neuropeptide biosynthesis and iron metabolism pathways.

Cancer Biology

What problem does this paper attempt to address?

This paper mainly investigates the role of the 11CYB561 gene in castration-resistant prostate cancer (CRPC), especially in neuroendocrine (NE) differentiated cells. The study found that the cytochrome b561 protein encoded by the 11CYB561 gene is highly expressed in NE cells and CRPC, and its expression is not regulated by androgens. This gene is involved in neuropeptide biosynthesis and iron metabolism pathways, both of which are often disrupted in cancer. By knocking down 11CYB561, the researchers observed its impact on neuroendocrine differentiation potential, iron levels, and cell growth and invasiveness, indicating that 11CYB561 plays a crucial role in maintaining the NE phenotype of CRPC and promoting disease progression. Therefore, this study aims to reveal the functional mechanisms of 11CYB561 in the deterioration of prostate cancer and formation of NEPC.